0113 2727560

Contact Us

Contact CPWY

Twitter Latest Tweets

Latest PSNC News

PSNC responds to RCGP's forecast of increasing waits for GP appointments

PSNC has today responded to a warning from the Royal College of General Practitioners (RCGP) that patients across England face waiting longer than a week for a GP or practice nurse appointment on more than 100 million occasions by 2022. The press release from RCGP states that, if current trends continue, the number of instances when patients...

13 hours ago

Ask PSNC: NUMSAS FAQs

The team at PSNC has received a number of queries on the NHS Urgent Medicine Supply Advanced Service (NUMSAS) since the service has gone live. Below are some of the questions asked in recent weeks. Q.Q. How do I claim payment for provision of NUMSAS? Contractors must complete the NHS Urgent Medicine Supply Advanced Service Claim submission...

20 hours ago

July 2017 Price Concessions/NCSO (further update)

The Department of Health has granted the following price concessions for July 2017: Drug Pack size Price concession Betahistine 16mg tablets 84 £11.95 Betahistine 8mg tablets 84 £5.85 Buspirone 10mg tablets 30 £9.57 Dapsone 50mg tablets 28 £46.19 Diamorphine 30mg powder for solution for injection ampoules 5 £16.52 Exemestane 25mg tablets (new) 30 £65.00 Levetiracetam 1g...

4 days ago

Essential Services

UNLICENSED MEDICINES CERTIFICATES OF CONFORMITY / CERTIFICATES OF ANALYSIS

Following discussions between the West Yorkshire CCGs and NHS England (West Yorkshire Area Team), it has been agreed that the Area Team no longer wish to receive Certificates Of Conformity from West Yorkshire pharmacies. It is recognised that this is a contractual obligation for pharmacies, however NHS England (West Yorkshire Area Team) undertake not to apply any contractual sanction in relation to Certificates Of Conformity if pharmacies choose not to send them in.  Community Pharmacy West Yorkshire is aware of this agreement.

In making this undertaking, NHS England (West Yorkshire Area Team) do reserve the right to re-instate the submission of Certificates Of Conformity in the future should any concerns be raised about the quality of medicinal products supplied, or to review those certificates held by any particular pharmacy where issues may occur.